Colorectal Cancer Prevention in the Alaska Tribal Health System
Diana Redwood, PhD, MPH
Alaska Native Tribal Health Consortium
At the conclusion of this activity, the healthcare team will be able to:
1. Examine the burden of colorectal cancer among Alaska Native people and rates of colorectal cancer screening.
2. Implement evidence-based program activities to increase colorectal cancer screening among Alaska Native people.
3. Appropriately assess, educate, and refer patients for colorectal screening and prevention.
Physicians, nurses, health educators, administrators, and support staff working with American Indian and/or Alaska Native communities.
Continuing Education (CE) Credit Information:
There is no registration fee to participate in this activity. In order to receive continuing education credit, learners must participate in the webinar in its entirety, and complete an online evaluation.
Please contact email@example.com if you have any questions or problems with the system.
In support of improving patient care, IHS Clinical Support Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. .
This activity was planned by and for the health care team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
The IHS Clinical Support Center designates this live activity for 1 hour of AMA PRA Category 1 Credit™ for each hour of participation. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designated 1.0 contact hour for each hour of participation.
Disclosure Statement: As a jointly funded accredited provider of continuing education, the IHS Clinical Support Center must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course directors/coordinators, planning committee members, faculty, reviewers and all others who are in a position to control the content of this educational activity are required to disclose the existence of all financial relationships with ineligible companies within the prior 24 months. Safeguards against commercial bias have been put in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. All those who are in a position to control the content of this educational activity have completed the disclosure process and have indicated that they do not have any relevant financial relationships or affiliations with any manufacturers or commercial products to disclose, with the exemption of:
• Diana Redwood, PhD, MPH, faculty for this educational event, receives in-kind support and screening kits from Exact Sciences Laboratory for the RO1 Study.
All of the relevant financial relationships listed have been mitigated.
There is no commercial support for this educational activity.
Funding for this webinar was made possible by the Centers for Disease Control and Prevention DP18-1808: Networking2Save: CDC’s National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations. Webinar contents do not necessarily represent the official views of the Centers for Disease Control and Prevention, and the Indian Health Service, or the Department of Health and Human Services.